1-6 of 6
Peter Trask
Close
Sort by
Journal Articles

Obinutuzumab Short Duration Infusion Is Preferred By Healthcare Providers and Has Minimal Impact on Patient-Reported Symptoms Among Patients with Untreated, Advanced Follicular Lymphoma

Peter Trask, Jaisson Bortolini, Shinya Rai, Antonio Salar, Miguel Canales, Dirk Klingbiel, Joana Parreira, Maud Deraet, Ekaterina Vorozheikina, Kai Hübel, Thomas Buchholz
Journal: Blood
Blood (2021) 138 (Supplement 1): 1345.
https://doi.org/10.1182/blood-2021-147911
Published: 2021
Journal Articles

Untreated Bleeds May Be Historically Under-Reported and More Prevalent in People with Hemophilia A with Inhibitors: An Examination of Bleed Data from a Prospective, Non-Interventional Study

Michael U. Callaghan, MD, Elina Asikanius, Michaela Lehle, Johannes Oldenburg, Johnny Mahlangu, Marianne Uguen, Sammy Chebon, Rebecca Kruse-Jarres, Victor Jimenez-Yuste, Midori Shima, MD PhD, Peter Trask, Christine L. Kempton, Craig M. Kessler, Gallia G. Levy, Elena Santagostino
Journal: Blood
Blood (2018) 132 (Supplement 1): 383.
https://doi.org/10.1182/blood-2018-99-118160
Published: 2018
Journal Articles

Geriatric Assessment (GA) Measures and Patient-Reported Outcomes (PROs) Among Older Adults Treated in a Phase 1b Study for Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)

Heidi D. Klepin, MD MS, Avrita Campinha-Bacote, Wan-Jen Hong, Patrick Phuong, Jue Wang, Mehrdad Mobasher, MD MPH, Peter Trask
Journal: Blood
Blood (2018) 132 (Supplement 1): 4076.
https://doi.org/10.1182/blood-2018-99-116038
Published: 2018
Journal Articles

Preference for Emicizumab over Prior Factor Treatments: Results from the HAVEN 3 and HAVEN 4 Studies

Victor Jimenez-Yuste, Midori Shima, MD PhD, Ido Paz-Priel, Aric Parnes, Michaela Lehle, Adam Giermasz, Avrita Campinha-Bacote, Markus Niggli, Jerzy Windyga, Sammy Chebon, Peter Trask, Johnny Mahlangu, Steven Pipe, Johannes Oldenburg
Journal: Blood
Blood (2018) 132 (Supplement 1): 1187.
https://doi.org/10.1182/blood-2018-99-118132
Published: 2018
Journal Articles

Development of a Concept-Driven Disease Impact Instrument from Patients with Hemophilia (Pediatric and Adult) and Caregivers

Jessica T. Markowitz, Esprit Ma, Paul Solari, Patrick Marquis, Amy D. Shapiro, MD, Barbara Konkle, MD, Peter Trask, Edmund Pezalla, Anna Christian, Michelle Rice, Wendy E. Owens, MA, Kimberly Haugstad, Yaping Xu, Richard H. Ko, Jennifer Whiteley, Robert F. Sidonio
Journal: Blood
Blood (2017) 130 (Supplement 1): 4732.
https://doi.org/10.1182/blood.V130.Suppl_1.4732.4732
Published: 2017
Journal Articles

Improvements in Health-Related Quality of Life and Symptoms in Patients with Previously Untreated Chronic Lymphocytic Leukemia: Results from the Phase II GIBB Study of the Combination of Obinutuzumab and Bendamustine

Jeffrey P. Sharman, MD, Habte Yimer, MD, Michael Boxer, MD, Nicholas Di Bella, Sunil Babu, Jia Li, PhD, Yong Mun, Peter Trask, Anthony Masaquel, MPH, PhD, Carolina M Reyes, PhD, Alexey Danilov, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 683.
https://doi.org/10.1182/blood.V130.Suppl_1.683.683
Published: 2017